1.An Unusual Type of Acute Renal Failure due to Extensive Crystal Deposition in the Renal Tubular Epithelium and Interstitium: A Case Report.
Ja Seung KOO ; Eunah SHIN ; Shin Woo KANG ; Hyeon Joo JEONG
Korean Journal of Pathology 2004;38(5):337-340
Acute tubular necrosis is a major cause of acute renal failure. Acute renal failure that is caused by crystal deposition can result from drug toxicity, lymphoplasmacytic neoplasms, ingestion of industrial organic solvents, or intratubular obstruction due to degenerated red blood cells and red blood cell casts. We herein present an uncommon case of acute renal failure in a 57-year-old woman showing an unusually massive accumulation of variable-sized, round, ellipsoid or rhomboid, pale-pink, refractile bodies in the proximal and distal tubular epithelial cells, interstitial macrophages and Bowman's spaces. These bodies were electron dense with a maximum diameter of 3 micrometer. The information we gathered from the patient history, the laboratory data and the various histochemical and immunohistochemical analyses failed to reveal the exact nature of these crystal-like structures.
Acute Kidney Injury*
;
Drug-Related Side Effects and Adverse Reactions
;
Eating
;
Epithelial Cells
;
Epithelium*
;
Erythrocytes
;
Female
;
Humans
;
Macrophages
;
Middle Aged
;
Necrosis
;
Renal Insufficiency
;
Solvents
2.Multifunctional Nanoparticles for Molecular Imaging.
Eunah KANG ; Kwangmeyung KIM ; Ick Chan KWON
Journal of the Korean Medical Association 2009;52(2):125-134
Molecular imaging is a bioimaging that can detect biochemically and genetically relevant events in molecular level in cells and tissues via quantitative imaging signal. Molecular imaging provides potential advantages to examine early diagnosis of specific diseases, to screen new candidates of a drug, to monitor therapeutic effects in real time, and to communicate with both diagnosis and therapeutics. These diverse advantages of molecular imaging can be allowed by development of nanoplatform technology. The nanoplatform-based probes for molecular imaging is widely investigated to grant multimodal molecular imaging and drug delivery together with medical imagings, which includes the issues of biocompatibility, targeting moiety, proteasespecific peptide substrate, quenching/dequenching system etc. In this paper, nanoplatformbased probes are reviewed in aspects of cancer targeting for diagnosis and therapy and multimodal molecular imaging with inorganic/organic hybrid nanoparticles.
Chimera
;
Early Diagnosis
;
Financing, Organized
;
Molecular Imaging
;
Nanoparticles
;
Organothiophosphorus Compounds
3.Multifunctional Nanoparticles for Molecular Imaging.
Eunah KANG ; Kwangmeyung KIM ; Ick Chan KWON
Journal of the Korean Medical Association 2009;52(2):125-134
Molecular imaging is a bioimaging that can detect biochemically and genetically relevant events in molecular level in cells and tissues via quantitative imaging signal. Molecular imaging provides potential advantages to examine early diagnosis of specific diseases, to screen new candidates of a drug, to monitor therapeutic effects in real time, and to communicate with both diagnosis and therapeutics. These diverse advantages of molecular imaging can be allowed by development of nanoplatform technology. The nanoplatform-based probes for molecular imaging is widely investigated to grant multimodal molecular imaging and drug delivery together with medical imagings, which includes the issues of biocompatibility, targeting moiety, proteasespecific peptide substrate, quenching/dequenching system etc. In this paper, nanoplatformbased probes are reviewed in aspects of cancer targeting for diagnosis and therapy and multimodal molecular imaging with inorganic/organic hybrid nanoparticles.
Chimera
;
Early Diagnosis
;
Financing, Organized
;
Molecular Imaging
;
Nanoparticles
;
Organothiophosphorus Compounds
4.Demographic characteristics of patients admitted to the emergency department for intoxication and a time series analysis during the COVID-19 period
Bongmin SON ; Nayoon KANG ; Eunah HAN ; Gina YU ; Junho CHO ; Jaiwoog KO ; Taeyoung KONG ; Sung Phil CHUNG ; Minhong CHOA
Journal of The Korean Society of Clinical Toxicology 2023;21(2):92-107
Purpose:
This study investigated the characteristics and treatment outcomes of patients who visited the emergency department due to intoxication and analyzed the impact of the coronavirus disease 2019 (COVID-19) pandemic on their visits.
Methods:
A retrospective study was conducted using data from the National Emergency Department Information System (NEDIS) on patients who visited the emergency department due to intoxication between January 2014 and December 2020. In total, 277,791 patients were included in the study, and their demographic and clinical data were analyzed. A model was created from 2014 to 2019 and applied to 2020 (i.e., during the COVID-19 pandemic) to conduct a time series analysis distinguishing between unexpected accidents and suicide/self-harm among patients who visited the emergency department.
Results:
The most common reason for visiting the emergency department was unintentional accidents (48.5%), followed by self-harm/suicide attempts (43.8%). Unexpected accident patients and self-harm/suicide patients showed statistically significant differences in terms of sex, age group, hospitalization rate, and mortality rate. The time series analysis showed a decrease in patients with unexpected accidents during the COVID-19 pandemic, but no change in patients with suicide/self-harm.
Conclusion
Depending on the intentionality of the intoxication, significant differences were found in the age group, the substance of intoxication, and the mortality rate. Therefore, future analyses of patients with intoxication should be stratified according to intentionality. In addition, the time series analysis of intentional self-harm/suicide did not show a decrease in 2010 in the number of patients, whereas a decrease was found for unintentional accidents.
5.Safety and efficacy of fimasartan with essential hypertension patients in real world clinical practice: data from a post marketing surveillance in Korea
Su Eun HAN ; Seung Hee JEONG ; Hye Jeong KANG ; Myung Sook HONG ; Eunah PAEK ; Hijung CHO ; Seong Choon CHOE
Translational and Clinical Pharmacology 2018;26(3):118-127
The safety and efficacy of fimasartan have been evaluated through post-marketing surveillance in real world clinical practice. The multi-center, prospective, open-label and non-interventional study. A total of 3,945 patients (3,729 patients for safety assessment and 3,473 patients for efficacy assessment) were screened in patients with essential hypertension in 89 study centers from 9 September 2010 through 8 September 2016. Among the total patients, 2,893 patients (77.6%) were administered fimasartan for 24 weeks or longer and were classified as ‘patients with long-term follow-up’, and the additional safety and efficacy analysis were performed. The improvement was defined as systolic blood pressure (SBP) controlled to ≤ 140 mmHg or decreased SBP differences ≥ 20 mmHg after treatment or diastolic blood pressure (DBP) controlled to ≤ 90 mmHg or decreased DBP differences ≥ 10 mmHg after treatment. Adverse drug reactions (ADRs) were reported in 3.8% patients; dizziness, and hypotension were the most frequently reported ADRs in total patients. The results of patients with long-term follow-up were comparable with total patients. The overall improvement rate in all efficacy assessment at the last visit was 87.1% (3,025/3,473 patients). The overall improvement rate of the patients with long-term follow-up was 88.9%. Fimasartan was well tolerated, with no new safety concerns identified and an effective treatment in the real world clinical practice for Korean patients with hypertension.
Blood Pressure
;
Dizziness
;
Drug-Related Side Effects and Adverse Reactions
;
Follow-Up Studies
;
Humans
;
Hypertension
;
Hypotension
;
Korea
;
Marketing
;
Prospective Studies
6.A Pathophysiological Validation of Collagenase II-Induced Biochemical Osteoarthritis Animal Model in Rabbit.
Jaeseong PARK ; Jungsun LEE ; Kang Il KIM ; Jisoo LEE ; Seoyoung JANG ; Hyun Tae CHOI ; Youngsook SON ; Hyung Joong KIM ; Eung Je WOO ; EunAh LEE ; Tong In OH
Tissue Engineering and Regenerative Medicine 2018;15(4):437-444
BACKGROUND: Current dilemma working with surgically-induced OA (osteoarthritis) model include inconsistent pathological state due to various influence from surrounding tissues. On the contrary, biochemical induction of OA using collagenase II has several advantageous points in a sense that it does not involve surgery to induce model and the extent of induced cartilage degeneration is almost uniform. However, concerns still exists because biochemical OA model induce abrupt destruction of cartilage tissues through enzymatic digestion in a short period of time, and this might accompany systemic inflammatory response, which is rather a trait of RA (rheumatoid arthritis) than being a trait of OA. METHODS: To clear the concern about the systemic inflammatory response that might be caused by abrupt destruction of cartilage tissue, OA was induced to only one leg of an animal and the other leg was examined to confirm the presence of systemic degenerative effect. RESULTS: Although the cartilage tissues were rapidly degenerated during short period of time upon biochemical induction of OA, they did not accompanied with RA-like process based on the histology data showing degeneration of articular cartilage occurred only in the collagenase-injected knee joint. Scoring evaluation data indicated that the cartilage tissues in non-induced joint remained intact. Neutrophil count transiently increase between day 8 and day 16, and there were no significant change in other complete blood count profile showing a characteristics of OA disease. CONCLUSION: These study shows that biochemically induced cartilage degeneration truly represented uniform and reliable OA state.
Animals*
;
Blood Cell Count
;
Cartilage
;
Cartilage, Articular
;
Clothing
;
Collagenases*
;
Digestion
;
Inflammation
;
Joints
;
Knee Joint
;
Leg
;
Models, Animal*
;
Neutrophils
;
Osteoarthritis*
;
Regeneration
7.Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea.
Gheun Ho KIM ; Bum Soon CHOI ; Dae Ryong CHA ; Dong Hyun CHEE ; Eunah HWANG ; Hyung Wook KIM ; Jae Hyun CHANG ; Joong Kyung KIM ; Jung Woo NOH ; Kwon Wook JOO ; Sang Choel LEE ; Sang Woong HAN ; Se Joong KIM ; Soo Wan KIM ; Sug Kyun SHIN ; Wondo PARK ; Won KIM ; Wooseong HUH ; Young Joo KWON ; Young Sun KANG
Kidney Research and Clinical Practice 2014;33(1):52-57
BACKGROUND: In many countries, nephrologists follow clinical practice guidelines for mineral bone disorders to control secondary hyperparathyroidism (SHPT) associated with abnormal serum calcium (Ca) and phosphorus (P) levels in patients undergoing maintenance hemodialysis (MHD). The Kidney Disease Outcomes Quality Initiative (KDOQI) Guidelines have long been used in Korea, and this study was undertaken to investigate the current status of serum Ca and P control in MHD patients. METHODS: Data were collected from a total of 1,018 patients undergoing MHD without intercurrent illness, in 17 hemodialysis centers throughout the country. Serum levels of Ca, P, and intact parathyroid hormone (iPTH) were measured over 1 year, and the average values were retrospectively analyzed. RESULTS: Serum levels of Ca, P, and the CaxP product were 9.1+/-0.7mg/dL, 5.3+/-1.4mg/dL, and 48.0+/-13.6mg2/dL2, respectively. However, the percentages of patients with Ca, P, and Ca x P product levels within the KDOQI guideline ranges were 58.7%, 51.0%, and 70.7%, respectively. Of the 1,018 patients, 270 (26.5%) had iPTH >300pg/mL (uncontrolled SHPT), whereas 435 patients (42.7%) showed iPTH <150pg/mL. Patients with uncontrolled SHPT had significantly higher values of serum Ca, P, and CaxP product than those with iPTH < or =300pg/mL. CONCLUSION: Despite the current clinical practice guidelines, SHPT seems to be inadequately controlled in many MHD patients. Uncontrolled SHPT was associated with higher levels of serum Ca, P, and Ca x P product, suggestive of the importance of SHPT management.
Calcium*
;
Humans
;
Hyperparathyroidism, Secondary
;
Kidney Diseases
;
Korea
;
Parathyroid Hormone
;
Phosphorus*
;
Renal Dialysis*
;
Retrospective Studies
8.Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study
Eunah CHUNG ; Jae Myoung NOH ; Kyu Chan LEE ; Jin Hee KIM ; Weon Kuu CHUNG ; Yang Gun SUH ; Jung Ae LEE ; Ki Ho SEOL ; Hong Gyun WU ; Yeon Sil KIM ; O Kyu NOH ; Jae Won PARK ; Dong Soo LEE ; Jihae LEE ; Young Suk KIM ; Woo Yoon PARK ; Min Kyu KANG ; Sunmi JO ; Yong Chan AHN
Cancer Research and Treatment 2019;51(3):1001-1010
PURPOSE: Lung Cancer Subcommittee of Korean Radiation Oncology Group (KROG) has recently launched a prospective clinical trial (KROG 17-06) of hippocampus-sparing whole brain radiotherapy (HS-WBRT) with simultaneous integrated boost (SIB) in treating multiple brain metastases from non-small cell lung cancer. In order to improve trial quality, dummy run studies among the participating institutions were designed. This work reported the results of two-step dummy run procedures of the KROG 17-06 study. MATERIALS AND METHODS: Two steps tested hippocampus contouring variability and radiation therapy planning compliance. In the first step, the variation of the hippocampus delineation was investigated for two representative cases using the Dice similarity coefficients. In the second step, the participating institutions were requested to generate a HS-WBRT with SIB treatment plan for another representative case. The compliance of the treatment plans to the planning protocol was evaluated. RESULTS: In the first step, the median Dice similarity coefficients of the hippocampus contours for two other dummy run cases changed from 0.669 (range, 0.073 to 0.712) to 0.690 (range, 0.522 to 0.750) and from 0.291 (range, 0.219 to 0.522) to 0.412 (range, 0.264 to 0.598) after providing the hippocampus contouring feedback. In the second step, with providing additional plan priority and extended dose constraints to the target volumes and normal structures, we observed the improved compliance of the treatment plans to the planning protocol. CONCLUSION: The dummy run studies demonstrated the notable inter-institutional variability in delineating the hippocampus and treatment plan generation, which could be decreased through feedback from the trial center.
Brain
;
Carcinoma, Non-Small-Cell Lung
;
Compliance
;
Hippocampus
;
Lung Neoplasms
;
Neoplasm Metastasis
;
Prospective Studies
;
Radiation Oncology
;
Radiotherapy